| AB SCIENCE S.A. EO-,01 |
| Frankreich |
| Gesundheit |
| FR0010557264 / A1CXBG |
| A8D (Frankfurt) |
| FRA:A8D, ETR:A8D, A8D:GR |
| - |
| https://www.ab-science.co.. |
|
AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, parti..
>Volltext.. |
| 61.63 Mio. EUR |
| 55.66 Mio. EUR |
| 1.2 Mio. EUR |
| -4.62 Mio. EUR |
| -1.6 Mio. EUR |
| -0.04 EUR |
| 4.34 Mio. EUR |
| 10.43 Mio. EUR |
| -4.4 Mio. EUR |
| 0.69 |
| 9.51% |
| 80.12% |
| - |
| - |
| - |
| - |
| AB SCIENCE |
| 19.06.26 |
|